...
首页> 外文期刊>American Journal of Physiology >NHE-1 inhibition improves cardiac mitochondrial function through regulation of mitochondrial biogenesis during postinfarction remodeling.
【24h】

NHE-1 inhibition improves cardiac mitochondrial function through regulation of mitochondrial biogenesis during postinfarction remodeling.

机译:NHE-1抑制通过在梗死后重塑过程中调节线粒体的生物发生来改善心脏线粒体的功能。

获取原文
获取原文并翻译 | 示例

摘要

We have recently demonstrated that mitochondrial respiratory dysfunction and mitochondrial permeability transition pore opening during postinfarction remodeling are prevented by the Na(+)/H(+) exchange-1 (NHE-1)-specific inhibitor EMD-87580 (EMD). One of the mechanisms underlying the beneficial effect of NHE-1 inhibition on mitochondria could result from the drug's ability to regulate transcriptional factors responsible for mitochondrial function. In the present study, the effect of EMD on the expression of nuclear factors involved in mitochondrial biogenesis and expression of nuclear (COXNUCSUB IV) and mitochondrial (COXMITSUB I) encoded cytochrome c oxidase subunits has been studied in rat hearts subjected to either 12 or 18 wk of coronary artery ligation (CAL). Remodeling induced an increase in expression of the hypertrophic marker gene atrial natriuretic peptide, especially 12 wk after CAL. The mRNA level of the peroxisome proliferator-activated receptor-gamma coactivator-1alpha and its downstream factors, including nuclear respiratory factor 1 and 2, mitochondrial transcription factor A, COXNUCSUB IV, and COXMITSUB I, were significantly reduced in hearts both 12 and 18 wk after ligation compared with sham-operated hearts. Dietary EMD provided immediately after ligation attenuated downregulation of mitochondrial transcription factors with a parallel decrease of hypertrophic marker gene expression. Regression analysis demonstrated a strong positive correlation between the transcription factors and mitochondrial respiratory function. Thus our study shows that the downregulation of mitochondrial transcription factors induced by postinfarction remodeling can be significantly attenuated by NHE-1 inhibition with a further improvement of mitochondrial function in these hearts.
机译:我们最近证明,Na(+)/ H(+)exchange-1(NHE-1)特异性抑制剂EMD-87580(EMD)可以防止梗死后重塑期间线粒体呼吸功能障碍和线粒体通透性转变开孔。 NHE-1抑制对线粒体产生有益作用的潜在机制之一可能是由于该药物调节负责线粒体功能的转录因子的能力。在本研究中,已经研究了EMD对参与12或18岁大鼠心脏的线粒体生物发生中涉及的核因子表达以及核(COXNUCSUB IV)和线粒体(COXMITSUB I)编码的细胞色素c氧化酶亚基表达的影响。冠状动脉结扎术(CAL)。重塑诱导肥大标记基因心钠素表达的增加,尤其是在CAL后12周。过氧化物酶体增殖物激活的受体-γcoactivator-1alpha及其下游因子(包括核呼吸因子1和2,线粒体转录因子A,COXNUCSUB IV和COXMITSUB I)的mRNA水平在12周和18周的心脏中均显着降低结扎后与假手术的心脏相比。结扎后立即提供饮食EMD,可减轻线粒体转录因子的下调,并同时减少肥大标志物基因的表达。回归分析表明,转录因子与线粒体呼吸功能之间存在强正相关。因此,我们的研究表明,由NHE-1抑制可显着减轻梗死后重塑诱导的线粒体转录因子的下调,并进一步改善这些心脏中的线粒体功能。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号